ArticleMolecular cancer therapeutics2018

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Hetal Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.